Dipanjan Banerjee Selected Research

Dipanjan Banerjee Research Topics

Disease

10	Heart Failure 03/2024 - 05/2013
6	Hemorrhage 12/2020 - 07/2014
5	Insulin Resistance 01/2023 - 06/2009
3	Obesity 01/2023 - 05/2022
3	Inflammation (Inflammations) 01/2023 - 01/2019
3	Arteriovenous Malformations (Arteriovenous Malformation) 01/2020 - 07/2014
3	Myocardial Infarction 06/2015 - 05/2013
3	Thrombosis (Thrombus) 10/2014 - 07/2014
2	Type 2 Diabetes Mellitus (MODY) 05/2022 - 01/2019
2	Cardiogenic Shock 08/2018 - 06/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2011
2	Cardiomyopathies (Cardiomyopathy) 08/2014 - 07/2014
1	Body Weight (Weight, Body) 01/2024
1	Chronic Kidney Failure (Chronic Renal Failure) 12/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Rare Diseases (Rare Disease) 01/2022
1	Coronary Stenosis (Coronary Artery Stenosis) 10/2021
1	Ischemia 10/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2021
1	End Stage Liver Disease 12/2020
1	Parkinsonian Disorders (Parkinsonism) 06/2020
1	Epilepsy (Aura) 06/2020
1	Dementia (Dementias) 06/2020
1	Pulmonary Hypertension 01/2020
1	Atherosclerosis 08/2018
1	False Aneurysm (Pseudoaneurysm) 06/2016
1	Infarction (Infarctions) 06/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2015
1	Angiodysplasia 01/2015
1	Encephalitis (Encephalitis, Rasmussen) 09/2014
1	Hemolysis 09/2014
1	Vascular Malformations 07/2014
1	Pyoderma Gangrenosum 09/2011
1	Pulmonary Arterial Hypertension 12/2010
1	Tuberculosis (Tuberculoses) 01/2009

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 01/2023 - 08/2018
3	CytokinesIBA 01/2023 - 01/2019
3	Thalidomide (Thalomid)FDA Link 01/2020 - 07/2014
2	Insulin (Novolin)FDA Link 01/2024 - 05/2013
2	Nonesterified Fatty Acids (NEFA)IBA 01/2023 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 06/2020 - 06/2009
1	Streptozocin (Streptozotocin)FDA Link 01/2024
1	mesoglycanIBA 12/2023
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	CholesterolIBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	PalmitatesIBA 05/2022
1	Cyclophilin AIBA 05/2022
1	CateninsIBA 05/2022
1	Clostridium perfringens epsilon-toxinIBA 10/2021
1	tau Proteins (tau Protein)IBA 07/2021
1	Hemoglobins (Hemoglobin)IBA 12/2020
1	Ion Channels (Ion Channel)IBA 06/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 06/2020
1	indirubinIBA 01/2019
1	pro-brain natriuretic peptide (1-76)IBA 01/2019
1	indirubin-3'-monoximeIBA 01/2019
1	AlkaloidsIBA 01/2019
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	Capsules (Microcapsules)IBA 10/2017
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2017
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2017
1	Angiotensin Receptor AntagonistsIBA 01/2017
1	Neprilysin (Neutral Endopeptidase)IBA 01/2017
1	Mineralocorticoid Receptor AntagonistsIBA 01/2017
1	ArgonIBA 07/2014
1	Azathioprine (Imuran)FDA LinkGeneric 09/2011
1	Lipoprotein(a)IBA 01/2011
1	Phosphodiesterase 5 InhibitorsIBA 12/2010
1	Glucose (Dextrose)FDA LinkGeneric 06/2009
1	AntigensIBA 01/2009

Therapy/Procedure

14	Heart-Assist Devices 10/2021 - 07/2014
5	Therapeutics 03/2024 - 01/2017
2	Heart Transplantation (Grafting, Heart) 03/2024 - 01/2020
1	Kidney Transplantation 12/2023
1	Precision Medicine 01/2022
1	Patient Readmission 01/2021
1	Artificial Respiration (Mechanical Ventilation) 12/2020
1	Length of Stay 12/2020
1	Sternotomy 12/2020
1	Contraindications 01/2020
1	Drug Tapering 01/2020
1	Argon Plasma Coagulation 07/2019
1	Extracorporeal Membrane Oxygenation 08/2018
1	Aftercare (After-Treatment) 01/2017
1	Percutaneous Coronary Intervention 06/2015
1	Highly Active Antiretroviral Therapy (HAART) 01/2015
1	Cannula 09/2014
1	Artificial Heart (Artificial Hearts) 09/2014
1	Microbubbles 09/2014
1	Catheters 08/2014
1	Laser Coagulation 07/2014